Home
Robin Shane Readnour, Director: AN2 Therapeutics ANTX Sell · Filed 24/01/17
Trade details
- Type
- Insider sale
- Amount
- $15,753.29
- Shares · price
- 719 sh · $21.91 a share
- Held after
- 485,073 sh
- Trade date
- 24/01/12
- Filed
- 24/01/17
- Days to filing
- 5 days
Sold 0.1% of holdings
- Share of holding sold
- 0.1%
AN2 Therapeutics trades, last 26 weeks
What else happened in AN2 Therapeutics around then
Filed or reported within 30 days of the trade day · 23/12/13~24/02/11Robin Shane Readnour's recent trades
- Robin Shane Readnour
Planned sale10b5-1 planAN2 Therapeutics
Planned sale10b5-1 planAN2 Therapeutics
ANTX
$6.1M
1,012,000 sh
$6.1M
Filed 08/17
Traded 08/17
- Robin Shane Readnour
BuyAN2 Therapeutics
BuyAN2 Therapeutics
ANTX
$26.4K
18,483 sh
$26.4K
Filed 24/12/10
Traded 24/12/09
- Robin Shane Readnour
BuyAN2 Therapeutics
BuyAN2 Therapeutics
ANTX
$18.4K
12,711 sh
$18.4K
Filed 24/12/10
Traded 24/12/06
- Robin Shane Readnour
BuyAN2 Therapeutics
BuyAN2 Therapeutics
ANTX
$17.6K
12,289 sh
$17.6K
Filed 24/12/10
Traded 24/12/09
- Robin Shane Readnour
BuyAN2 Therapeutics
BuyAN2 Therapeutics
ANTX
$9,450
6,517 sh
$9,450
Filed 24/12/10
Traded 24/12/06